| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |